Le Dr. Guillaume B. Fond, titulaire d'un doctorat en médecine et ancien chef de clinique des Hôpitaux, occupe actuellement le poste éminent de psychiatre au sein des Hôpitaux Universitaires de Marseille. En parallèle, il partage son expertise en tant qu'enseignant au sein de l'Université d'Aix-Marseille, à l'École de médecine - Campus médical de la Timone. Son engagement dans le domaine de la recherche est tout aussi remarquable, en tant que chercheur au sein de l'EA 3279 : CEReSS - Centre de recherche sur les services de santé et la qualité de vie, situé à Marseille, en France. Il figure parmi les cinq premiers publicateurs scientifiques Français en santé mentale.
L'éminence de son parcours se reflète notamment dans son rôle crucial entre 2013 et 2016, où il a exercé en tant que coordinateur exécutif, en collaboration avec le Pr Pierre-Michel Llorca, au sein du réseau de centres d'experts en schizophrénie de la Fondation FondaMental. Ce réseau, initié par le ministère français de la recherche pour stimuler la recherche en psychiatrie, a permis de suivre attentivement de vastes cohortes de patients souffrant de schizophrénie. Il se consacre désormais à la coordination des centres experts dépressions résistantes et schizophrénies de la région PACA, ainsi que de l'institut de data science en santé mentale.
L'ampleur de ses contributions scientifiques est tout à fait impressionnante. Le Dr. Fond et son équipe comptent parmi les auteurs ou co-auteurs de plus de 300 publications internationales, rigoureusement évaluées par des pairs. Son influence se manifeste également à travers plus de 100 présentations et la rédaction de 8 chapitres de livres spécialisés.
Au-delà de son engagement académique, le Dr. Fond s'est également illustré en tant qu'auteur prolifique de quatre ouvrages destinés au grand public. Parmi ces titres figurent "Devenez la meilleure Version de Vous-même en 3 étapes" (Ellipses), "Je fais de ma vie un Grand Projet" (Flammarion), "Voyage au cœur de la souffrance" (Jc Lattes) et "Bien manger pour ne plus déprimer" (Odile Jacob).
La reconnaissance de son expertise se matérialise par son affiliation à diverses sociétés savantes, attestant de sa contribution significative au domaine médical et psychiatrique. Son excellence a également été consacrée par l'obtention du prestigieux prix European Congress of Neuropsychopharmacology en 2016, ainsi que par deux distinctions honorifiques du prix de la meilleure publication scientifique en psychiatrie lors du Congrès Français de Psychiatrie.
En somme, le Dr. Guillaume B. Fond incarne une figure éminente et polyvalente, alliant ses rôles de clinicien, d'enseignant, de chercheur et d'auteur, au service de l'avancement de la médecine et de la psychiatrie.
Experience
-
2017–presentIntervenant, Université Pierre et Marie Curie
-
2012–2016Enseignant-Chercheur associé, Université Paris-Est
-
2010–2012Chef de clinique-Enseignant, Université Montpellier 1
Education
-
2016Congrès Français de psychiatrie, Prix de la meilleure publication scientifique
-
2016European congress of NeuroPsychopharmacology, Award meilleur publication en psychiatrie- catégorie jeune chercheur
-
2011Congrès de l'Encéphale- Paris, Prix du meilleur poster scientifique
Publications
-
2017Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set., European Archives of Psychiatry and clinical Neuroscience
-
2017Would I take antipsychotics, if I had psychotic symptoms? Examining determinants of the decision to take antipsychotics., Prog Neuropsychopharmacol Biol Psychiatry.
-
2017Advanced paternal age is associated with earlier schizophrenia onset in offspring. Results from the national multicentric FACE-SZ cohort., Psychiatry research
-
2017Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort., European Archives of Psychiatry and clinical Neuroscience
-
2017Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset., European Archives of Psychiatry and clinical Neuroscience
-
2016Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset., Journal of clinical Psychiatry
-
2016[Reflection on the psychiatric financial allocation in France]., Encephale
-
2016Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset., Schizophrenia Research
-
2016Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort., Schizophrenia Research
-
2016(Mis)use of Prescribed Stimulants in the Medical Student Community: Motives and Behaviors: A Population-Based Cross-Sectional Study., Medicine (Baltimore)
-
2016C-reactive protein as a differential biomarker of bipolar II depression versus major depressive disorder., World J Biol Psychiatry
-
2016Interleukin-1 β-targeted treatment strategies in inflammatory depression: toward personalized care., Acta Psychiatrica Scandinavica
-
2016Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia., Schizophrenia Research
-
2016Violent behavior and aggression in schizophrenia: Prevalence and risk factors. A multicentric study from three Latin-America countries., Schizophrenia Research
-
2016Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set., European Archives of Psychiatry and clinical Neuroscience
-
2016Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia., Schizophrenia Research
-
2016Medication and aggressiveness in "real world" schizophrenia: current issues and perspectives., Psychopharmacology (Berl)
-
2016Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset., Schizophrenia Bulle
-
2016Potentially inappropriate psychotropic prescription at discharge is associated with lower functioning in the elderly psychiatric inpatients. A cross-sectional study., Psychopharmacology (Berl)
-
2016Disparities in suicide mortality trends between United States of America and 25 European countries: retrospective analysis of WHO mortality database., Scientific Reports
-
2015Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia., Psychiatry research
-
2015The promise of biological markers for treatment response in first-episode psychosis: a systematic review., Schizophrenia Bulletin
-
2015A National network of schizophrenia expert centres: An innovative tool to bridge the research-practice gap., European Psychiatry
-
2015Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia., Schizophrenia Research
-
2015Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study., Journal of Psychiatric Research
-
2015Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset., Psychopharmacology (Berl)
-
2015Ketamine vs other anesthetic agents for electroconvulsive therapy (ECT) in major depression., Journal of Psychiatric Research
-
2015Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review., Psychiatry research
-
2015Google Trends: Ready for real-time suicide prevention or just a Zeta-Jones effect? An exploratory study., Psychiatry research
-
2015Ketamine's effectiveness in unipolar versus bipolar depression., Psychopharmacology (Berl)
-
2015A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depression., Scientific Reports
-
2015Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort., Schizophrenia Research
-
2015Pharmacoterrorism: the potential role of psychoactive drugs in the Paris and Tunisian attacks., Psychopharmacology (Berl)
-
2015[The potential role of microbiota in major psychiatric disorders: Mechanisms, preclinical data, gastro-intestinal comorbidities and therapeutic options]., La Presse Medicale
-
2015Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset., Psychopharmacology (Berl)
-
2015The World Health Organization (WHO) dataset for guiding suicide prevention policies: A 3-decade French national survey., Journal of affective disorders
-
2015Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set., Journal of affective disorders
-
2015Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis., Acta Psychiatrica Scandinavica
-
2015Do the treasures of 'big data' combined with behavioural intervention therapies contain the key to the mystery of large psychiatric issues?, Acta Psychiatrica Scandinavica
-
2015Ketamine administration in depressive disorders: a systematic review and meta-analysis., Psychopharmacology (Berl)
-
2014Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis., European Archives of Psychiatry and clinical Neuroscience
-
2014Fasting in mood disorders: neurobiology and effectiveness. A review of the literature., Psychiatry research
-
2014Nanopsychiatry--the potential role of nanotechnologies in the future of psychiatry: a systematic review., European NeuroPsychopharmacology
-
2014Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate., European Archives of Psychiatry and clinical Neuroscience
-
2014Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review., Acta Psychiatrica Scandinavica
-
2014D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis., Psychopharmacology (Berl)
Honours
Prix de la meilleure publication en psychiatrie, Congrès Français de Psychiatrie, 2016
- Marseille, France
- Website
- Article Feed
-
For media enquiries,
guillaume.fond@gmail.com - ORCID
- Joined
